AmpleLogic Turns 15; Marked in an Evening Filled with Celebrations and Inspiration

July 22, 2024 09:09 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

HYDERABAD, India, July 22, 2024 /PRNewswire/ -- AmpleLogic, a leader in providing GAMP (Good Automated Manufacturing Practices) solutions, celebrated its 15th anniversary with a grand event on July 19, 2024, at Sandhya Convention, Hyderabad. The evening was filled with inspiring speeches, captivating dance performances, and a fashion show highlighting the company's journey and achievements over the past decade and a half.

Dr. Krishna Mohan, Executive Director of Bharat Biotech, graced AmpleLogic’s 15th Annual Day event
Dr. Krishna Mohan, Executive Director of Bharat Biotech, graced AmpleLogic’s 15th Annual Day event

The Chief Guests, Dr. Vamsi, CEO of HETERO Group, and Dr. Krishna Mohan, Executive Director of Bharat Biotech, Graced the event. Dr. Krishna Mohan delivered a speech emphasizing the importance of innovation and excellence in vaccine manufacturing automation and the importance of product building in IT instead of traditional software Services. Dr. Vamsi, CEO of Hetero, joined the celebration and shared the decade-long association between Hetero Group and Amplelogic in Quality Control and Quality Assurance Areas.

"Our goal is to achieve 10x growth in the next three years. This ambitious target reflects our commitment to innovation, excellence, and our team's dedication," said Mr. Manne V. Chowdary, CEO of AmpleLogic.

The celebration included leadership and performance awards, which recognized employees' outstanding contributions. The awards ceremony underscored a commitment to fostering a culture of excellence and teamwork. One of the highlights of the evening was the fashion show, which showcased a blend of Bollywood (Ethnic and Western) styles, adding a touch of glamour and entertainment to the event.

AmpleLogic offers an Application Platform as a Service (aPaaS) for the Lifesciences industry. The platform utilizes low-code/no-code technology to enhance operational efficiency and regulatory compliance with USFDA, MHRA, EMEA, ISO, and GAMP standards. The platform's Build Your Own Application (BYOA) feature enables swift customization to meet emerging regulatory needs.

AmpleLogic also offers the below-listed GAMP solutions:

  • Annual Product Quality Review Software
  • Quality Management System
  • Manufacturing Execution System
  • Electronic Logbook System
  • Environmental Monitoring System
  • Document Management System
  • Learning Management System
  • Cleaning Validation System
  • Process Validation System
  • Stability Management System
  • Regulatory Information Management System
  • Laboratory Information Management System
  • User Access Management System
  • Calibration and PM Software

These solutions are designed for regulated industries like pharmaceuticals, biotechnology, and medical devices. Integrating AI and ML, AmpleLogic provides advanced solutions for predictive analysis and automated SOP-based questionnaire generation, ensuring compliance and operational excellence.

About AmpleLogic

AmpleLogic offers high-quality, regulatory-compliant solutions for life sciences, helping streamline operations and growth.

For more information, visit: www.amplelogic.com

AmpleLogic Employees: Group Picture
AmpleLogic Employees: Group Picture

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.